There are many exciting therapeutic applications for proteins. Many diseases are caused by faulty enzymes, which can sometimes be replaced. Antibodies and antibody-like molecules are being developed to specifically target cancers and other diseases. However, in order to administer these products, they must be made in a way that has minimal effect on the patients immune system. To make them viable commercially, they also have to be made in a robust, cost-effective process.